Related Experiment Video
Updated: Oct 3, 2026

Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders
Published on: August 18, 2016
QT interval prolongation and torsades de pointes unmasked by intracoronary acetylcholine administration
M Chinushi1, I Nakagawa, T Hori
1First Department of Internal Medicine, Niigata University School of Medicine, Japan. chinushi@med.niigata-u.ac.jp
Insights
Intracoronary acetylcholine challenge revealed a prolonged QT interval and torsades de pointes in a patient. This occurred despite a normal QT interval at rest, highlighting a potential diagnostic challenge.
Area of Science:
- Cardiology
- Clinical Electrophysiology
- Pharmacology
Background:
- Coronary artery vasospasm is often diagnosed using intracoronary acetylcholine testing.
- The QT interval, a measure of ventricular repolarization, is crucial for assessing arrhythmia risk.
Observation:
- Intracoronary acetylcholine administration was performed to rule out vasospasms.
- The patient exhibited a normal QT interval prior to the acetylcholine challenge.
Findings:
- Acetylcholine administration unmasked significant QT interval prolongation.
- The unmasked QT prolongation triggered episodes of torsades de pointes, a life-threatening ventricular arrhythmia.
Implications:
- Intracoronary acetylcholine testing can reveal latent cardiac electrical abnormalities.
- This case underscores the importance of monitoring the QT interval during provocative pharmacologic testing.
- Consideration of QT prolongation during acetylcholine challenge is vital for preventing potentially fatal arrhythmias.
Abstract:
Intracoronary acetylcholine administration, which was performed to exclude vasospasms, unmasked an abnormal QT interval prolongation and initiated torsades de pointes in a patient with normal QT interval at rest.
Related Concept Videos
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Depolarizing Blockers: Pharmocokinetics
Acute Coronary Syndrome I: Introduction
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...

